OPTIMINE Trademark

Trademark Overview


On Tuesday, February 3, 2015, a trademark application was filed for OPTIMINE with the United States Patent and Trademark Office. The USPTO has given the OPTIMINE trademark a serial number of 86522903. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 23, 2018. This trademark is owned by IPL Therapeutics, LLC. The OPTIMINE trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines
optimine

General Information


Serial Number86522903
Word MarkOPTIMINE
Filing DateTuesday, February 3, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 23, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesAntihistamines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 12, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIPL Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Party NameIPL Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Monday, July 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, December 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2017EXTENSION 4 GRANTED
Wednesday, December 13, 2017EXTENSION 4 FILED
Wednesday, December 13, 2017TEAS EXTENSION RECEIVED
Friday, June 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2017EXTENSION 3 GRANTED
Wednesday, May 31, 2017EXTENSION 3 FILED
Wednesday, May 31, 2017TEAS EXTENSION RECEIVED
Thursday, December 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 7, 2016EXTENSION 2 GRANTED
Friday, December 2, 2016EXTENSION 2 FILED
Friday, December 2, 2016TEAS EXTENSION RECEIVED
Thursday, July 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2016EXTENSION 1 GRANTED
Friday, June 10, 2016EXTENSION 1 FILED
Saturday, July 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 10, 2016TEAS EXTENSION RECEIVED
Friday, February 5, 2016ASSIGNED TO EXAMINER
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 6, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, July 23, 2015EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 8, 2015ASSIGNED TO EXAMINER
Thursday, February 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 6, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords


optimine antihistamines